Inflammatory Bowel and Immunobiology Research Institute Inflammatory Bowel and Immunobiology Research Institute Toggle mobile sub-nav

Inflammatory Bowel & Immunobiology Research Institute Team

Nine components of a large, multidisciplinary force of more than 120 individuals dedicated to improving the lives of people with IBD.

The experts at the Inflammatory Bowel and Immunobiology Research Institute (IBIRI) work to fulfill our "bench to bedside" approach to care. By rapidly integrating new discoveries into patient treatment plans, these dedicated professionals helped Cedars-Sinai become an international leader in gastroenterology and gastrointestinal surgery.

Stephan R. Targan, MD

Feintech Family Chair in Inflammatory Bowel Disease, Director, Inflammatory Bowel Disease Center, Director, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute

Faculty

Robert Barrett, PhD

Janine Bilsborough, PhD

Director, Drug Discovery and Development

Jonathan Braun, MD, PhD

Director, IBD Enterprise Operations

David Casero, PhD

Suzanne Devkota, PhD

Rivkah Gonsky, PhD

Phillip Gu, MD

Edward Feldman, MD

Director, IBD Psychosocial Program

Phillip Fleshner, MD

Director, IBD Surgery Research

Talin Haritunians, PhD

Dalin Li, PhD

Gislaine Martins, PhD

Dermot P. McGovern, MD, PhD

Director of IBD Translational Medicine

Gil Y. Melmed, MD

Director, IBD Clinical Research, Co-director, IBD Clinical Operations

Kathrin Michelsen, PhD

Shervin Rabizadeh, MD

Director, IBD Clinical Operations and Pediatric IBD Research

David M. Underhill, PhD

Director, IBD Basic Science Research

Eric Vasiliauskas, MD

Director, Nutrition & Integrative IBD

Ivan Vujkovic-Cvijin, PhD

Andrea Wolf, PhD

Laura Wozniak, MD

Andres Yarur, MD

David Ziring, MD

Have Questions or Need Help?

Contact us if you have questions or wish to learn more about the IBIRI.

Inflammatory Bowel & Immunobiology Research Institute
8700 Beverly Blvd.
Davis Building, Suite D4063
Los Angeles CA 90048